Br J Obstet Gynaecol. 1999 Apr;106(4):371-2.

Calculating correct Down's syndrome risks.

Source

Centre for Reproduction, Growth and Development, University of Leeds, UK.

Abstract

Women having both first trimester nuchal translucency and second trimester serum screening tests are likely to receive two different Down's syndrome risks. Neither will be correct, and we describe how to calculate a valid combined risk. This uses the reported serum-based risk and a likelihood ratio derived from the nuchal translucency report. Tables, figures and examples are provided to aid the calculation of the likelihood ratio from either the nuchal translucency in multiples of the normal median, the nuchal translucency and crown-rump length in millimetres, or the reported prior and nuchal translucency-based risks.

Comment in

Br J Obstet Gynaecol. 1999 Sep;106(9):1001-2.

PMID:: 10426246; [PubMed - indexed for MEDLINE]

MeSH Terms, Substances

MeSH Terms

Substances

Biological Markers

LinkOut - more resources

Full Text Sources

EBSCO

Medical

Supplemental Content

Related citations

SURUSS in perspective. [Semin Perinatol. 2005]
SURUSS in perspective.
Wald NJ, Rodeck C, Hackshaw AK, Rudnicka A. Semin Perinatol. 2005 Aug; 29(4):225-35.
SURUSS in perspective. [BJOG. 2004]
SURUSS in perspective.
Wald NJ, Rodeck C, Hackshaw AK, Rudnicka A. BJOG. 2004 Jun; 111(6):521-31.
The effect of nuchal translucency measurement on second-trimester biochemical screening for Down's syndrome. [Ultrasound Obstet Gynecol. 1997]
The effect of nuchal translucency measurement on second-trimester biochemical screening for Down's syndrome.
Kadir RA, Economides DL. Ultrasound Obstet Gynecol. 1997 Apr; 9(4):244-7.
Review Advances in prenatal screening for Down syndrome: II first trimester testing, integrated testing, and future directions. [Clin Chim Acta. 2002]
Review Advances in prenatal screening for Down syndrome: II first trimester testing, integrated testing, and future directions.
Benn PA. Clin Chim Acta. 2002 Oct; 324(1-2):1-11.
Review Integrating antenatal Down's syndrome screening. [Curr Opin Obstet Gynecol. 2001]
Review Integrating antenatal Down's syndrome screening.
Cuckle H. Curr Opin Obstet Gynecol. 2001 Apr; 13(2):175-81.

See reviews... See all...

Recent activity

Clear Turn Off Turn On

Calculating correct Down's syndrome risks.
Calculating correct Down's syndrome risks.
Br J Obstet Gynaecol. 1999 Apr ;106(4):371-2.

PubMed
Investigation of white matter structure in velocardiofacial syndrome: a diffusio...
Investigation of white matter structure in velocardiofacial syndrome: a diffusion tensor imaging study.
Am J Psychiatry. 2003 Oct ;160(10):1863-9.

PubMed
Air-oxygen flowmeter confusion.
Air-oxygen flowmeter confusion.
Anaesthesia. 2003 Feb ;58(2):194-5.

PubMed
Xanthogranulomatous mastitis: clinicopathology and pathological implications.
Xanthogranulomatous mastitis: clinicopathology and pathological implications.
Pathol Int. 2009 Apr ;59(4):234-40.

PubMed
Air and oxygen flowmeter confusion.
Air and oxygen flowmeter confusion.
J R Soc Med. 2008 Nov ;101(11):526.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Calculating correct Down's syndrome risks.

Source

Abstract

Comment in

MeSH Terms, Substances

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Supplemental Content

Related citations

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information